From Wikipedia, the free encyclopedia
Chemical compound
Pemafibrate
|
|
Trade names | Parmodia |
---|
Other names | K-13675 |
---|
Routes of administration | Oral |
---|
ATC code | |
---|
|
Legal status |
- In general: ℞ (Prescription only)
|
---|
|
(2R)-2-[3-({1,3-Benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino}methyl)phenoxy]butanoic acid
|
CAS Number | |
---|
ChemSpider | |
---|
UNII | |
---|
KEGG | |
---|
ChEBI | |
---|
ChEMBL | |
---|
CompTox Dashboard (
EPA) | |
---|
|
Formula | C28H30N2O6 |
---|
Molar mass | 490.556 g·mol−1 |
---|
3D model (
JSmol) | |
---|
CC[C@H](C(=O)O)Oc1cccc(c1)CN(CCCOc2ccc(cc2)OC)c3nc4ccccc4o3
|
InChI=1S/C28H30N2O6/c1-3-25(27(31)32)35-23-9-6-8-20(18-23)19-30(28-29-24-10-4-5-11-26(24)36-28)16-7-17-34-22-14-12-21(33-2)13-15-22/h4-6,8-15,18,25H,3,7,16-17,19H2,1-2H3,(H,31,32)/t25-/m1/s1 Key:ZHKNLJLMDFQVHJ-RUZDIDTESA-N
|
Pemafibrate, sold under the brand namd Parmodia, is a
peroxisome proliferator-activated receptor alpha (PPARα) agonist. It is developed and marketed by
Kowa Pharmaceuticals.
[1]
In July 2017,
Pharmaceuticals and Medical Devices Agency approved it in Japan.
[2][
failed verification]
References
|
---|
PPARαTooltip Peroxisome proliferator-activated receptor alpha | |
---|
PPARδTooltip Peroxisome proliferator-activated receptor delta | |
---|
PPARγTooltip Peroxisome proliferator-activated receptor gamma | |
---|
Non-selective | |
---|
|